Preclinical Development of Anti-FLT3 CAR-T Therapy for the Treatment of Acute Myeloid Leukemia

被引：5
|
作者：
Shrestha, Elina
Liang, Raymond
Sirochinsky, Carina
Ben Jehuda, Ronen
Sandler, Vladislav
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-142745
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Evolving strategies to overcome barriers in CAR-T cell therapy for acute myeloid leukemia
    Colonne, Chanukya K.
    Kimble, Erik L.
    Turtle, Cameron J.
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (11) : 797 - 818
  • [22] Efficacy and safety of an anti-FLT3 antibody (LY3012218) in patients with relapsed acute myeloid leukemia.
    Sanford, David
    Blum, William G.
    Ravandi, Farhad
    Klisovic, Rebecca B.
    Borthakur, Gautam
    Walker, Alison R.
    Garcia-Manero, Guillermo
    Marcucci, Guido
    Wierda, William G.
    Whitman, Susan P.
    Kantarjian, Hagop M.
    Cortes, Jorge E.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [23] CAR-T Cells Immunotherapies for the Treatment of Acute Myeloid Leukemia-Recent Advances
    Zarychta, Julia
    Kowalczyk, Adrian
    Krawczyk, Milena
    Lejman, Monika
    Zawitkowska, Joanna
    CANCERS, 2023, 15 (11)
  • [24] CAR-T engager proteins for the treatment of B cell cancers and acute myeloid leukemia
    Rennert, Paul D.
    Su, Lihe
    Wu, Lan
    Lobb, Roy R.
    Ambrose, Christine
    CANCER RESEARCH, 2022, 82 (12)
  • [25] Preclinical Development of a CAR-T Cell Approach Targeting the CD84 Antigen Associated to Pediatric Acute Myeloid Leukemia
    Pigazzi, Martina
    Marini, Olivia
    Porcu, Elena
    Faggin, Giovanni
    Varotto, Elena
    Rizzardi, Paolo
    Buldini, Barbara
    Locatelli, Franco
    Biffi, Alessandra
    BLOOD, 2022, 140 : 10247 - 10248
  • [26] FLT3, a prognostic biomarker for acute myeloid leukemia (AML): Quantitative monitoring with a simple anti-FLT3 interaction and flow cytometric method
    Ampasavate, Chadarat
    Jutapakdee, Wasimon
    Phongpradist, Rungsinee
    Tima, Singkome
    Tantiworawit, Adisak
    Charoenkwan, Pimlak
    Chinwong, Dujrudee
    Anuchapreeda, Songyot
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2019, 33 (04)
  • [27] Overexpression of CXCR4 Enhances the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia
    Biondi, Marta
    Galimberti, Stefania
    Cerina, Beatrice
    Tomasoni, Chiara
    Dotti, Gianpietro
    Tettamanti, Sarah
    Biondi, Andrea
    Pievani, Alice
    Serafini, Marta
    BLOOD, 2022, 140 : 4500 - 4501
  • [28] New target of interest for developing CAR-T in acute myeloid leukemia?
    Helene, Gardeney
    Maria-Pilar, Gallego-Hernanz
    HEMATOLOGIE, 2022, 28 (01): : 13 - 15
  • [29] Preclinical Development of FLT3-Redirected Chimeric Antigen Receptor T Cell Immunotherapy for Acute Myeloid Leukemia
    Chien, Christopher Daniel
    Sauter, Christopher Tor
    Ishii, Kazusa
    Sang Minh Nguyen
    Shen, Feng
    Tasian, Sarah K.
    Chen, Weizao
    Dimitrov, Dimiter S.
    Fry, Terry J.
    BLOOD, 2016, 128 (22)
  • [30] ALLO-819, an Allogeneic Flt3 CAR T Therapy Possessing an Off-Switch for the Treatment of Acute Myeloid Leukemia
    Sommer, Cesar
    Djuretic, Ivana
    Valton, Julien
    Duy Nguyen
    Sutton, Janette
    Poulsen, Kris
    Smith, Julianne
    Djuretic, Ivana
    Chaparro-Riggers, Javier
    Sasu, Barbra
    BLOOD, 2018, 132
12345